ERCC5 and lung carcinoma: As shown in Table 5, the ERCC5 rs873601 was related to overall survival in additive and recessive model in age > 56 years lung cancer patients (Additive model: p = 0.032; Recessive model: p = 0.004) and smoker patients in additive and recessive model (Additive model: p = 0.048; Recessive model: p = 0.018).